-5%
Indacaterol + Glycopyrronium + Mometasone Furoate- This combination is prescribed for the maintenance treatment of asthma in adults whose asthma is not adequately controlled with a combination of a long-acting beta2-agonist (LABA) and an inhaled corticosteroid (ICS). It is also effective in reducing asthma exacerbations.
Ultivent M Cozycap is an inhalation powder designed to deliver a triple combination of:
- Indacaterol Acetate (Ultra-LABA): A long-acting bronchodilator that acts locally in the lungs by stimulating beta2-adrenergic receptors. It provides rapid onset and sustained bronchodilation.
- Glycopyrronium Bromide (Ultra-LAMA): A long-acting muscarinic antagonist that prevents bronchoconstriction by inhibiting acetylcholine’s action on airway smooth muscle.
- Mometasone Furoate (ICS): A potent synthetic corticosteroid with a high affinity for glucocorticoid receptors. It reduces inflammation in the airways by inhibiting leukotriene release.